Komori
Statutory disclosure document4572Carna Biosciences,Inc.Pharmaceuticals

Report on the Transfer of Shares Issued Through a Third-Party Allotment (New Shares)

Athos Asia Event Driven Master Fund, the allottee in the third-party allotment, transferred a portion of the allotted shares to Macquarie Bank Limited. Following the transfer, the allottee continues to enjoy the economic gains and losses from these shares.

Worth reading
54Recurring
Scored from 5 of 6 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
500800
Shares
Wording
Definitive
How definitive the wording is.

Decision and Details

Transfer of shares allotted through a third-party allotment

Implementation27 April 2026 (actual)
AmountTransfer price: ¥389 per share
Quantity / scaleNumber of shares transferred: 500,800 shares; number of shares allotted: 1,050,600 shares; cumulative number of shares transferred: 616,400 shares (as of 27 April 2026)
Reason

The shares were transferred to a swap position. Athos Asia Event Driven Master Fund continues to enjoy the economic gains and losses from these shares after the transfer.

Decision and Details
ItemDetails
Matter CoveredTransfer of shares allotted through a third-party allotment
Implementation Date27 April 2026 (actual)
AmountTransfer price: ¥389 per share
Quantity / scaleNumber of shares transferred: 500,800 shares; number of shares allotted: 1,050,600 shares; cumulative number of shares transferred: 616,400 shares (as of 27 April 2026)
ReasonThe shares were transferred to a swap position. Athos Asia Event Driven Master Fund continues to enjoy the economic gains and losses from these shares after the transfer.
Related previous disclosuresThe allocation of the Company's shares through a third-party allotment on 11 October 2024
Items this document does not state (6)
Decision-Making BodyDecision DatePeriod CoveredImpact on Business PerformanceGoverning RuleFuture plans

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because the shares were transferred to a swap position. Athos Asia Event Driven Master Fund continues to enjoy the economic gains and losses from these shares after the transfer.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Report on the Transfer of Shares Issued Through a Third-Party Allotment (New Shares) | Carna Biosciences,Inc. (4572) timely disclosure | Komori